PNC Financial Services Group
FHTX icon

PNC Financial Services Group’s Foghorn Therapeutics FHTX Stock Holding History

PNC Financial Services Group’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625 Buy
128
+35
+38% +$155 ﹤0.01% 4934
2026
Q1 		$445 Buy
93
+9
+11% +$49 ﹤0.01% 4942
2025
Q4 		$454 Sell
84
-71
-46% -$322 ﹤0.01% 4861
2025
Q3 		$758 Sell
155
-178
-53% -$944 ﹤0.01% 4730
2025
Q2 		$1.56K Buy
333
+192
+136% +$802 ﹤0.01% 4481
2025
Q1 		$515 Buy
141
+109
+341% +$497 ﹤0.01% 4641
2024
Q4 		$151 Hold
32
– – ﹤0.01% 4678
2024
Q3 		$298 Hold
32
– – ﹤0.01% 4631
2024
Q2 		$184 Buy
+32
New +$191 ﹤0.01% 4677

Other funds holding FHTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

PNC Financial Services Group's FHTX Position: Q2 2026 in Review

PNC Financial Services Group increased its Foghorn Therapeutics (FHTX) stake by 38% in Q2 2026, buying an estimated $155 and bringing the position to 128 shares worth $625. The position accounts for ﹤0.01% of the portfolio, ranked #4934.

PNC Financial Services Group first reported a position in FHTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.56K in Q2 2025. 33 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • PNC Financial Services Group held 128 shares of Foghorn Therapeutics worth $625 as of Q2 2026.
  • PNC Financial Services Group bought 35 Foghorn Therapeutics shares in Q2 2026, an estimated $155.
  • Foghorn Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4934 holding.
  • PNC Financial Services Group first reported a position in Foghorn Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • PNC Financial Services Group's Foghorn Therapeutics position peaked at $1.56K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.